"Repressor Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release.
Descriptor ID |
D012097
|
MeSH Number(s) |
D12.776.260.703 D12.776.930.780
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Repressor Proteins".
Below are MeSH descriptors whose meaning is more specific than "Repressor Proteins".
This graph shows the total number of publications written about "Repressor Proteins" by people in this website by year, and whether "Repressor Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 4 | 1 | 5 |
1995 | 3 | 2 | 5 |
1996 | 2 | 1 | 3 |
1997 | 1 | 0 | 1 |
1998 | 7 | 0 | 7 |
1999 | 2 | 5 | 7 |
2000 | 6 | 4 | 10 |
2001 | 4 | 4 | 8 |
2002 | 10 | 6 | 16 |
2003 | 7 | 2 | 9 |
2004 | 10 | 2 | 12 |
2005 | 7 | 3 | 10 |
2006 | 9 | 5 | 14 |
2007 | 6 | 3 | 9 |
2008 | 8 | 6 | 14 |
2009 | 8 | 2 | 10 |
2010 | 12 | 13 | 25 |
2011 | 11 | 4 | 15 |
2012 | 13 | 7 | 20 |
2013 | 22 | 6 | 28 |
2014 | 6 | 7 | 13 |
2015 | 16 | 2 | 18 |
2016 | 4 | 3 | 7 |
2017 | 12 | 3 | 15 |
2018 | 10 | 2 | 12 |
2019 | 7 | 3 | 10 |
2020 | 6 | 4 | 10 |
2021 | 4 | 2 | 6 |
2022 | 1 | 3 | 4 |
2023 | 0 | 4 | 4 |
2024 | 4 | 4 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Repressor Proteins" by people in Profiles.
-
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis. Nat Genet. 2024 Oct; 56(10):2132-2143.
-
NAC1 promotes stemness and regulates myeloid-derived cell status in triple-negative breast cancer. Mol Cancer. 2024 Sep 06; 23(1):188.
-
Combinatorial control of Pseudomonas aeruginosa biofilm development by quorum-sensing and nutrient-sensing regulators. mSystems. 2024 Sep 17; 9(9):e0037224.
-
PHF6 suppresses self-renewal of leukemic stem cells in AML. Leukemia. 2024 Sep; 38(9):1938-1948.
-
CUX1 regulates human hematopoietic stem cell chromatin accessibility via the BAF complex. Cell Rep. 2024 May 28; 43(5):114227.
-
Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader. J Med Chem. 2024 May 09; 67(9):6938-6951.
-
Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy. Cell Rep. 2024 May 28; 43(5):114141.
-
PU.1 and BCL11B sequentially cooperate with RUNX1 to anchor mSWI/SNF to poise the T cell effector landscape. Nat Immunol. 2024 May; 25(5):860-872.
-
Global repression by tailless during segmentation. Dev Biol. 2024 Jan; 505:11-23.
-
RBFOX2 recognizes N6-methyladenosine to suppress transcription and block myeloid leukaemia differentiation. Nat Cell Biol. 2023 09; 25(9):1359-1368.